Your browser doesn't support javascript.
loading
AKT can modulate the in vitro response of HNSCC cells to irreversible EGFR inhibitors.
Silva-Oliveira, Renato José; Melendez, Matias; Martinho, Olga; Zanon, Maicon F; de Souza Viana, Luciano; Carvalho, André Lopes; Reis, Rui Manuel.
Afiliação
  • Silva-Oliveira RJ; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
  • Melendez M; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
  • Martinho O; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
  • Zanon MF; Life and Health Sciences Research Institute (ICVS), Health Sciences School, University of Minho, Braga, Portugal.
  • de Souza Viana L; ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.
  • Carvalho AL; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
  • Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
Oncotarget ; 8(32): 53288-53301, 2017 Aug 08.
Article em En | MEDLINE | ID: mdl-28881811
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article